Dublin, May 24, 2022 (GLOBE NEWSWIRE) -- The "Infectious Disease Diagnostic Testing: World Market Analysis" report has been added to ResearchAndMarkets.com's offering.
This report examines the global market for infectious disease testing products.
The report also examines the global demand for infectious disease IVD products, which is projected to increase as medical providers and healthcare organizations throughout the world heighten efforts to combat proliferating epidemic threats.
Infectious disease testing comprises one of the largest and fastest growing applications served by the global in vitro diagnostics (IVD) industry. Infectious diseases are ailments caused by pathogenic microorganisms that invade the body, either directly or indirectly via afflicted carriers or contaminated sources. IVD tests for these conditions are designed to detect and identify the responsible pathogen, pinpoint its origin, and determine appropriate antimicrobial therapy.
Infectious disease IVD products include reagents, consumables, and instruments based primarily on immunoassays, molecular technologies, and conventional microbiology techniques. Specific types of tests are available for detecting hundreds of pathogenic conditions.
Market Drivers
The report examines market drivers, including external market influences that are promoting the development and use of improved infectious disease diagnostics.
Public health officials worldwide have begun to recognize the global nature of infectious diseases - they are no longer solely a problem of developing countries but touch the very fabric of the social and economic welfare of countries in the industrialized world as well.
Over the long term, aging populations and problems posed by infectious diseases will strain healthcare resources in many countries.
Specific applications analyzed include:
-
Healthcare-associated and opportunistic infections
-
Antimicrobial-resistant pathogens including bacteria, fungi, parasites, and viruses
-
Human immunodeficiency virus (HIV) and hepatitis viruses
-
Diseases related to women's health and sexually transmitted infections (STDs)
-
Emerging, neglected, and tropical disease threats
-
Respiratory tract infections and respiratory viruses (including COVID-19)
Competitive Landscape
The report details the major competitors that are global market leaders in infectious disease testing products and technologies, including an overview and an outline of these company's infectious disease IVD products:
-
Abbott Laboratories
-
Becton, Dickinson and Company (BD)
-
bioMerieux Inc.
-
Bio-Rad Laboratories, Inc.
-
Bruker Corporation
-
DiaSorin S.p.A.
-
Grifols
-
Hologic, Inc.
-
Ortho-Clinical Diagnostics
-
QIAGEN N.V.
-
Quidel Corporation
-
Roche
-
Siemens AG
-
Thermo Fisher Scientific Inc.